Work

A Retrospective Analysis of VeriStrat Status on Outcome of a Randomized Phase II Trial of First-Line Therapy with Gemcitabine, Erlotinib, or the Combination in Elderly Patients (Age 70 Years or Older) with Stage IIIB/IV Non–Small-Cell Lung Cancer

Year: 2013

Type: article

Source: Journal of Thoracic Oncology

DOI: 10.1097/jto.0b013e3182835577

Authors: Thomas E. Stinchcombe, Joanna Roder, Amy H. Peterman, Julia Grigorieva, Carrie B. Lee, Dominic T. Moore, Mark A. Socinski

Institutions: University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Charlotte, UPMC Hillman Cancer Center

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2038989435

FWCI: 9.207

Cites: 24

Cited by: 51

Related to: 10